Enantiospecific Approaches To Pupukeanones, Trans-alpha-Himachalene And 8,9-Seco-Taxanes

Enantiospecific Approaches To Pupukeanones, Trans-alpha-Himachalene And 8,9-Seco-Taxanes

Bibliographic Details
Main Author:	Ravi Kumar, P
Other Authors:	Srikrishna, A
Language:	en_US
Published:	2011
Subjects:	Terpenes Papukeanones Himachalene 8,9-seco-Taxanes (-)-2-pupukeanone Taxanes Organic Chemistry
Online Access:	http://etd.iisc.ernet.in/handle/2005/1313 http://etd.ncsi.iisc.ernet.in/abstracts/1702/G18600-Abs.pdf

Similar Items

Enantiospecific Syntheses Of Cucumin-H, Pacifigorgianes And BC-Ring System Of Taxanes
by: Dethe, Dattatraya Hanumant
Published: (2011)

Radical cyclisation based approaches to 9-pupukeanone and lignan precursors
by: Danialdoss, S
Published: (2005)

Synthetic approaches to taxanes
by: Berry, N. M.
Published: (1987)

Synthesis amongst taxanes
by: Harrison, A. G.
Published: (1986)

Radical Cyclisation Based Approaches To 9-Pupukeanone And Lignan Precursors
by: Danialdoss, S
Published: (2012)

Synthesis Of 6-Epijunicedranol ; Spirocyclopentannulation Strategies ; And Exploratory Studies Towards Chiral Taxanes
by: Praveen Kumar, P
Published: (2012)

Effects of adding taxane to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer
by: Azra Rašić, et al.
Published: (2019-02-01)

Taxanes in the Treatment of Advanced Gastric Cancer
by: Byung Woog Kang, et al.
Published: (2016-05-01)

Taxane-Induced Upper Gastrointestinal Bleeding
by: Yao Liu, et al.
Published: (2021-09-01)

Taxane-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2015-04-01)

Taxane-induced morphea in a patient with CREST syndrome
by: Susan Michele Bouchard, et al.
Published: (2010-07-01)

New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer
by: E V Artamonova, et al.
Published: (2013-06-01)

Mechanisms of Taxane Resistance
by: Sara M. Maloney, et al.
Published: (2020-11-01)

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01)

Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands
by: Francisco de Asís Balaguer, et al.
Published: (2019-03-01)

Taxane-based adjuvant chemotherapy in node positive, early stage Turkish breast cancer patients
by: Alacacioglu Ahmet, et al.
Published: (2009-12-01)

Successful Treatment with Taxane-Based Chemotherapy in Advanced Sebaceous Carcinoma: A Case Report and Literature Review
by: Shuji Ota, et al.
Published: (2019-01-01)

Friedel-Craft Acylation of ar-Himachalene: Synthesis of Acyl-ar-Himachalene and a New Acyl-Hydroperoxide
by: Abdallah Karim, et al.
Published: (2011-07-01)

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers
by: Tarek M. A. Abdel-Fatah, et al.
Published: (2019-08-01)

Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer
by: Imai H, et al.
Published: (2018-09-01)

Endothelin Receptor A Blockade Enhances Taxane Effects in Prostate Cancer
by: Ardavan Akhavan, et al.
Published: (2006-09-01)

Beau’s Lines Resulting from Taxane Chemotherapy
by: Kumpol Aiempanakit
Published: (2018-10-01)

Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
by: van Eerden RAG, et al.
Published: (2020-10-01)

Paclitaxel and other taxanes in hazelnut
by: Angela Hoffman, et al.
Published: (2009-01-01)

The effect of pregabalin and duloxetine treatment on quality of life of breast cancer patients with taxane-induced sensory neuropathy: A randomized clinical trial
by: Razieh Avan, et al.
Published: (2018-01-01)

Taxane therapy in the adjuvant treatment of breast cancer in Italy: economic evaluation
by: Simona Ravera, et al.
Published: (2006-03-01)

Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
by: Wanjing Chen, et al.
Published: (2021-02-01)

Microtubule Destabilizing Sulfonamides as An Alternative to Taxane-Based Chemotherapy
by: Myriam González, et al.
Published: (2021-02-01)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
by: Neriman Yükseltürk Simsek, et al.
Published: (2018-01-01)

Assessment of pulmonary toxicities in breast cancer patients undergoing treatment with anthracycline and taxane based chemotherapy and radiotherapy- a prospective study
by: Aramita Saha, et al.
Published: (2013-12-01)

CLINICAL ASSESSMENT OF TAXANES IN THE FIRST-LINE CYTOTOXIC THERAPY OF CASTRATION-RESISTANT PROSTATE CANCER
by: A. A. GRITSKEVICH, et al.
Published: (2016-12-01)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
by: Eun Hee Sohn, et al.
Published: (2021-04-01)

Cognitive Effects and Depression Associated With Taxane-Based Chemotherapy in Breast Cancer Survivors: A Meta-Analysis
by: Eiman Y. Ibrahim, et al.
Published: (2021-04-01)

The Impact of SBF2 on Taxane-Induced Peripheral Neuropathy
by: Cunningham, Geneva Mari
Published: (2021)

Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis
by: Guo-Ying Liu, et al.
Published: (2018-05-01)

Taxanes in adjuvant and neoadjuvant therapy for breast cancer
by: S. V. Limareva
Published: (2014-08-01)

Eribulin drug review
by: Nishitha Shetty, et al.
Published: (2014-01-01)

Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas
by: Martina Catalano, et al.
Published: (2021-04-01)

Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer Models
by: Samantha S. Yee, et al.
Published: (2021-07-01)

Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy
by: Matteo Lambertini, et al.
Published: (2019-07-01)

Cannot write session to /tmp/vufind_sessions/sess_jo5l23dcl1heijj29cuffg6q9p